United States · FDA National Drug Code directory
CHOLESTYRAMINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70771-1105_8ad37d77-a00f-433b-a21a-4b063f4b887d
- Product NDC
- 70771-1105
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- CHOLESTYRAMINE
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180801
- Source listing expiry
- 20271231
Source-listed ingredients
- CHOLESTYRAMINE — 4 g/9g
These values do not establish equivalence or a dose recommendation.
Packages
- 378 g in 1 CAN (70771-1105-1) · 70771-1105-1
- 60 POUCH in 1 CARTON (70771-1105-2) / 9 g in 1 POUCH · 70771-1105-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →